Biosciences announced positive and significant topline results from its Phase 2 BREAKTHROUGH clinical trial evaluating ...
The wave of pipeline prioritization initiatives implemented last year has shown up in the data, with Phesi tracking a jump in terminations of phase 2 clinical trials and a fall in activity in certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback